Luye Pharma Group Ltd (LUP) — Cash Flow Reinvestment Rate
Luye Pharma Group Ltd (LUP) has a Cash Flow Reinvestment Rate of 0.52x as of June 2023, reinvesting €180.80 Million (capex €0.00 plus investments €180.80 Million) from operating cash flow of €344.86 Million. See how much free cash does Luye Pharma Group Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Luye Pharma Group Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Luye Pharma Group Ltd across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Luye Pharma Group Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Luye Pharma Group Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Luye Pharma Group Ltd. See Luye Pharma Group Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.03x | €3.62 Billion | €1.78 Billion | €1.00 Billion | ▼ -88.2% |
| 2024 | 17.16x | €2.88 Billion | €167.76 Million | €1.71 Billion | ▲ +1246.2% |
| 2023 | 1.27x | €2.03 Billion | €1.60 Billion | €1.17 Billion | ▼ -25.3% |
| 2022 | 1.71x | €2.82 Billion | €1.65 Billion | €1.16 Billion | ▼ -88.1% |
| 2021 | 14.33x | €2.61 Billion | €182.37 Million | €556.20 Million | ▲ +645.0% |
| 2020 | 1.92x | €1.99 Billion | €1.03 Billion | €692.81 Million | ▲ +106.8% |
| 2019 | 0.93x | €1.32 Billion | €1.42 Billion | €999.34 Million | ▼ -26.5% |
| 2018 | 1.27x | €1.32 Billion | €1.05 Billion | €728.16 Million | ▲ +61.2% |
| 2017 | 0.78x | €756.56 Million | €964.10 Million | €507.32 Million | ▼ -78.4% |
| 2016 | 3.64x | €2.15 Billion | €592.03 Million | €319.14 Million | — |